Compare Organon Pharma Indonesia Tbk. (SCPI) vs Teladan Prima Agro Tbk. (TLDN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Teladan Prima Agro Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Teladan Prima Agro Tbk. trades at Rp615 (market cap 8.22T, 1.81M 24h volume). The key difference: Teladan Prima Agro Tbk. is far larger — about 78.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TLDN | |
|---|---|---|
Market Cap | 104.4B | 8.22T |
Volume | — | 1.81M |
Lot | — | 18.15K |
Turnover | — | 1.11B |
Average Price | — | 613.91 |
Value | — | 1.11B |
Indicative Equilibrium Price | — | 615 |
Indicative Equilibrium Volume | — | 19 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Teladan Prima Agro Tbk.
PT Teladan Prima Agro Tbk ( formerly PT Sandaran Prima Sawit ) was established in the Republic of Indonesia on May 10, 2004 based on the Notarial Deed No. 22 of Imas Fatimah, S.H. On May 25, 2012, the Company's shareholders approved the proposed merger with PT Teladan Agro Resources (“TAR”) where the Company is the recipient of the merger (“Penggabungan 2012”).
Read more on TLDN →
